Manufacturers Scramble To Meet Looming Unique Device Identification Deadline – But Too Many Are Unprepared
Executive Summary
US FDA and device industry experts are concerned that too many firms are woefully unprepared for, and undereducated about, the agency's Unique Device Identification program. A recent industry survey appears to bear this out: A whopping 85% of respondents say they're not ready for the upcoming UDI compliance deadline of Sept. 24 for makers of class II products. Meanwhile, firms asking for UDI exceptions for their devices are waiting an inordinate amount of time for FDA to come to a decision, in part because the agency simply doesn't know how to publicly disclose the exemptions, UDI guru Jay Crowley says. Also: experts mull over the agency's latest UDI guidance; FDA explains why using an HL7 UDI submission option for its GUDID database isn't a good idea for every firm; and Crowley discusses what the UDI landscape will look like in 2020.
You may also be interested in...
QUALITY REPLAY: Walking The Document Control Tightrope – How Manufacturers Can Toe The Line
From our digital archives: Document control violations typically occur when manufacturers don’t have procedures or fail to ensure that document changes are applied systemically, FDA says. Experts also advise firms to schedule periodic document reviews and have a centralized document control group. “Don’t assume that everyone knows about document control,” says Karen St. Onge, a QA official at NxStage Medical.
UDI Extensions: Convenience Kits, Repackaged Devices, Combo Products
Just a little more than two weeks before the next Unique Device Identification compliance date, US FDA has granted two-year extensions to three product categories that raise particular complications for UDI labeling.
GMDN Agency Flooded With Requests For Device Terms Ahead Of US UDI Deadline
Medical device-makers rushing to meet US FDA's upcoming Sept. 24 Unique Device Identification deadline for class II products are flooding the Global Medical Device Nomenclature Agency with requests for new or revised terms that they need to correctly add their products to FDA's UDI database.